Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroaryl amidines, methylamidines and guanidines, and use thereof as protease inhibitors

Heteroaryl amidines, methylamidines and guanidines, and use thereof as protease inhibitors

US Patent 6403633 · Granted Jun 11, 2002

Estimated economic value: $1,705,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and 2025
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)2025
Compounds for improving mRNA splicing2023
C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and 2023
Autophagy modulators for use in treating cancer2022
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)2022
Benzo-fused heterocyclic derivatives useful as agonists of GPR1202022
Autophagy inducers for treatment of CNS conditions2022
Cyclodextrin for the treatment of lysosomal storage diseases2021
Substituted pyrazolopyrimidines as glucocerebrosidase activators2021
Benzo-fused heterocyclic derivatives useful as agonists of GPR1202020
Compounds for improving mRNA splicing2020